04/03/2024
11:15 PM | Pyxis Oncology (Filer)
| Form EFFECT | |
03/28/2024
3:31 PM | Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:32 PM | Civik Thomas (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:32 PM | HUMPHREY RACHEL (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:33 PM | Cline Darren S (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:33 PM | Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:33 PM | Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/27/2024
6:49 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
6:44 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:54 PM | Palani Santhosh (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:45 PM | Palani Santhosh (Reporting)
Pyxis Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/13/2024
3:31 PM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:02 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:28 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Pyxis Oncology (Subject)
| Form SC 13G/A | |
12/29/2023
3:33 PM | Kobayashi Ken (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
3:50 PM | Kobayashi Ken (Reporting)
Pyxis Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/28/2023
6:22 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:44 PM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:46 PM | Pyxis Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023
3:34 PM | Pyxis Oncology (Filer)
| Form 8-K/A | |
09/28/2023
3:32 PM | Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2023
5:36 PM | Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2023
5:37 PM | Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2023
6:04 PM | Dupont Jakob (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
4:05 PM | Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
4:04 PM | Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:34 PM | Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:35 PM | Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
6:03 PM | Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
3:26 PM | Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
3:43 PM | Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
7:16 PM | Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
3:47 PM | Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
3:35 PM | Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
3:46 PM | Pyxis Oncology (Subject)
Sullivan Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
4:08 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2023
4:28 PM | Dupont Jakob (Reporting)
Pyxis Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/25/2023
4:30 PM | Dupont Jakob (Reporting)
Pyxis Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
11:15 PM | Pyxis Oncology (Filer)
| Form EFFECT | |
08/23/2023
4:28 PM | Pyxis Oncology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/23/2023
4:28 PM | Pyxis Oncology (Filer)
| Form POS AM | |
New crypto project uncovers 2,050% in 65 days (Ad) During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price.
I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. |
08/23/2023
4:30 PM | Pyxis Oncology (Filer)
| Form S-8 POS | |
08/23/2023
7:47 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
4:00 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2023
6:25 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
6:26 AM | Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
| Form 425 | |
08/11/2023
6:31 AM | Pyxis Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023
5:34 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
5:35 AM | Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
| Form 425 | |
07/31/2023
3:41 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/28/2023
9:18 AM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144/A | |
07/21/2023
3:27 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2023
12:27 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2023
11:15 PM | Pyxis Oncology (Filer)
| Form EFFECT | |
06/30/2023
3:30 PM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:31 PM | Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
| Form 425 | |
06/16/2023
2:22 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
7:03 AM | Pyxis Oncology (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
06/07/2023
6:12 PM | Feingold Jay (Reporting)
Pyxis Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2023
3:41 PM | Pyxis Oncology (Subject)
| Form 425 | |
05/25/2023
7:14 AM | Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Apexigen, Inc. (Subject)
Pyxis Oncology (Filed by)
| Form 425 | |
05/24/2023
5:59 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
6:03 AM | Pyxis Oncology (Subject)
| Form 425 | |
05/24/2023
6:05 AM | Apexigen, Inc. (Filed by)
Apexigen, Inc. (Filed by)
Apexigen, Inc. (Filed by)
Pyxis Oncology (Subject)
| Form 425 | |
05/11/2023
6:16 AM | Pyxis Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
6:19 AM | Pyxis Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2023
3:25 PM | Pyxis Oncology (Filer)
| Form DEF 14A | |
04/28/2023
3:28 PM | Pyxis Oncology (Filer)
| Form DEFA14A | |
